Royal Marsden NHS Foundation Trust
New trial — Tracking Mutations in Cell Free Tumour DNA to Predict Relapse in Early Colorectal Cancer
New trial
70/100
Opportunity
Commercial fit23/25
Clinical timing13/20
Biomarker need15/20
Relationship2/10
Signal strength9/10
Account value7/10
Urgency1/5
New unknown trial NCT04050345 posted by Royal Marsden NHS Foundation Trust: "Tracking Mutations in Cell Free Tumour DNA to Predict Relapse in Early Colorectal Cancer". New trial on a unknown recruiting study is a moment when external vendors are commonly selected or expanded (spec §70).
Why nowClinicalTrials.gov record updated 816 days ago.
ConfidenceHigh · 95%